About
Dune Medical Devices has developed tissue characterization technology that can be used for a broad range of diagnostic and therapeutic applications and offers surgeons and radiologists the ability to detect cancer in real time. The company's MarginProbe System delivers real-time cancer detection in the operating room through a simple assessment of the margin of excised tissue. The key element of the MarginProbe System is its Fringe Field Sensor. Positioned at the tip of the probe, the highly responsive sensor emits a precisely controlled electromagnetic field and captures the tissue's response. The sensor identifies signals in close range to the edge of the tissue, the critical focus of margin assessment. The company is also developing a smart biopsy system. The system will expand the company's surgical oncology portfolio to include a soft tissue biopsy system with its first indication in breast tissue. This project has received funding from the European Union's Horizon 2020 research and innovation program.
Funding history · 4 rounds · $53.8M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary status of Dune Medical Devices as of April 2020?
- Dune Medical Devices was acquired by Dilon Technologies in April 2020 and is currently inactive.
- What is Dune Medical Devices' core technology?
- Dune Medical Devices has developed tissue characterization technology that uses a Fringe Field Sensor to detect cancer in real time, particularly for margin assessment of excised tissue.
- What is the total amount of funding raised by Dune Medical Devices?
- Dune Medical Devices raised a total of $53.8 million USD across multiple funding rounds. For a full financing history, please refer to startupim.
- Which investors participated in Dune Medical Devices' Series C funding round in October 2014?
- In October 2014, Dune Medical Devices closed a Series C round with participation from Apax Partners, Canepa Healthcare, The Kraft Group, and Medtech Advisors.
- What is the purpose of Dune Medical Devices' MarginProbe System?
- The MarginProbe System by Dune Medical Devices provides real-time cancer detection in the operating room by assessing the margin of excised tissue.
- What new product was Dune Medical Devices developing with European Union funding?
- Dune Medical Devices was developing a smart biopsy system, funded by the European Union's Horizon 2020 program, to expand its surgical oncology portfolio with an initial indication in breast tissue.
- When did Dune Medical Devices receive its last reported grant?
- Dune Medical Devices received a grant of $3,000,000 from the IIA in August 2016.
- What was a key finding from new research on MarginProbe in May 2018?
- New research in May 2018 showed that MarginProbe reduced re-excision rates for breast conserving surgery by 61%.